- Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
-
Guntram Schernthaner
-
Diabetes Metab J. 2021;45(4):615-616. Published online July 30, 2021
-
DOI: https://doi.org/10.4093/dmj.2021.0081
-
-
4,075
View
-
72
Download
-
2
Web of Science
-
2
Crossref
-
 PDF PubReader  ePub
-
Citations
Citations to this article as recorded by  - The risk of common hypoglycemic and antihypertensive medications and COVID-19: A 2-sample Mendelian randomization study
Ya Wang, Kai Li, Jiaxing Zeng, Shunyu Lu, Wangsheng Deng
Medicine.2024; 103(6): e36423. CrossRef - The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
Leszek Czupryniak, Dror Dicker, Roger Lehmann, Martin Prázný, Guntram Schernthaner
Cardiovascular Diabetology.2021;[Epub] CrossRef
|
KDA
